HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High molecular weight microtubule-associated protein 2 over-expression in neuronal migration disorders caused by N-methyl-D-aspartate receptor activation in hamsters.

Abstract
To evaluate the neuronal cytoarchitectural changes in neuronal migration disorders, the immunohistochemical expression of microtubule-associated proteins (MAPs) was analyzed using the experimental model induced by ibotenate in newborn hamsters. The cortical lesions observed after intracerebral ibotenate injections strongly resembled the following neuronal migration disorders: (1) microgyria; (2) focal subcortical heterotopia; (3) focal subependymal heterotopia; and (4) leptomeningeal glioneuronal heterotopia. Microgyria and leptomeningeal glioneuronal heterotopia had MAP2 (HM-2: high and low-molecular-weight forms of MAP2) immunoreactive dendritic processes or neuronal elements. The high molecular weight isoform of MAP2 (AP-20), which is more characteristic of mature neurons, showed enhanced expression in neurons of focal subcortical or subependymal heterotopia, although MAP1B (AA6: early form of MAP) immunoreactive elements were not detected in these heterotopic areas. We conclude that high molecular weight isoform of MAP2 is closely associated with cytoarchitectural repair and remodeling of neuronal processes, resulting in neuronal heterotopia after NMDA receptor activation.
AuthorsTomoyuki Takano, Chihiro Sawai, Yoshihiro Takeuchi
JournalCongenital anomalies (Congenit Anom (Kyoto)) Vol. 44 Issue 1 Pg. 33-40 (Mar 2004) ISSN: 0914-3505 [Print] Australia
PMID15008898 (Publication Type: Journal Article)
Chemical References
  • Microtubule-Associated Proteins
  • Receptors, N-Methyl-D-Aspartate
Topics
  • Animals
  • Cell Movement (physiology)
  • Cerebral Cortex (pathology)
  • Choristoma (metabolism, pathology)
  • Cricetinae
  • Immunohistochemistry
  • Microtubule-Associated Proteins (genetics, metabolism)
  • Neurons (metabolism)
  • Receptors, N-Methyl-D-Aspartate (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: